MedChem Symposium

MedChemmedchembanner.jpg  

Organized by
Dr. Ben Pratt, Dr. Mark Tichenor, Dr. David Wallace - San Diego Section of the American Chemical Society
Dr. Emmanuel Theodorakis - UCSD Department of Chemistry & Biochemistry

 

Register here!

TIME AGENDA
8:30 AM Registration and Continental Breakfast
9:00 AM Opening Remarks: Emmanuel Theodorakis
9:05 AM Simon Planken, Pfizer
“Discovery of PF-06747775 through Structure Based Drug Design: a covalent inhibitor of the EGFR T790M mutant” 
9:50 AM Dr. Thomas Hermann, University of California San Diego
"Small Molecule Targeting of Viral Noncoding RNA”
10:35 AM Coffee Break
10:50 AM Dr. Arnab Chatterjee, California Institute for Biomedical Research (Calibr)
“Intra-muscular injections for malaria chemoprotection”
11:35 AM Dr. Holly Reichard, Takeda Pharmaceuticals
“Discovery of TAK-041: Potent and selective GPR139 agonist for treatment of negative symptoms associated with schizophrenia"
12:20 PM Lunch
1:20 PM Dr. Jin-Quan Yu, The Scripps Research Institute
“Enantioselective and Remote C–H Activation Reactions”
2:05 PM Dr. Justin Cisar, Abide Therapeutics
“Discovery of ABX-1431: A Potent and Selective MGLL Inhibitor for Clinical Development”
2:50 PM Symposium Conclusion

 

REGISTRATION:

http://www-chem.ucsd.edu/graduate-program/Events/medchem/registraton.html
Register online by Friday, July 13 and food will be provided.

 

DIRECTIONS:

http://www-chem.ucsd.edu/graduate-program/Events/medchem/directions.html

 

THANK YOU TO OUR SPONSORS!

medchem_sponsors_banner.jpg

 Speakers:

Simon Planken
Simon Planken

Pfizer

 Dr. Thomas Hermann
Dr. Thomas Hermann

UC San Diego

Dr. Arnab Chatterjee
Dr. Arnab Chatterjee

Calibr

Dr. Holly Reichard
Dr. Holly Reichard

Takeda Pharmaceuticals

Dr. Jin-Quan Yu
Dr. Jin-Quan Yu

TSRI

Dr. Justin Cisar
Dr. Justin Cisar

Abide Therapeutics